Report: Biotech industry raised $1.3B in Q2 venture funding

07/22/2013 | American City Business Journals

Biotechnology companies secured $1.3 billion in venture capital investments during the second quarter of 2013, a 41% increase compared with the previous quarter, according to a new MoneyTree Report. The number of biotech-related deals grew 4%, to 103. "Life sciences investment is poised for a slow and steady recovery, provided we can continue to see progress on the regulatory front," National Venture Capital Association President Mark Heesen said.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL